论文部分内容阅读
肺是肿瘤转移的“靶”器官,恶性肿瘤的肺转移率高达40～50%。转移性肺癌约占整个肺癌病人的十分之一。今后随着肿瘤治疗上的进展,癌肿病人生命期的延长,转移性肺癌的病例必将继续增多。过去认为,发生肺转移是癌肿的晚期表现,治疗无望。但近年来大量的临床资料和研究表明,积极开展转移性肺癌的外科手术,配合化疗和放疗等措施,可使其预后大为改观,不少病人可获得长期生存。现就其主要的治疗方法作一概述。
The lung is the “target” organ of tumor metastasis, and the lung metastasis rate of malignant tumors is as high as 40-50%. Metastatic lung cancer accounts for about one-tenth of the entire lung cancer patient. In the future, as cancer treatment progresses and the life span of cancer patients is prolonged, cases of metastatic lung cancer will continue to increase. In the past, it was thought that the occurrence of lung metastasis was a late manifestation of cancer and treatment was hopeless. However, in recent years, a large number of clinical data and studies have shown that active surgical treatment of metastatic lung cancer, combined with chemotherapy and radiotherapy and other measures, can greatly improve its prognosis, many patients can obtain long-term survival. Here is an overview of the main treatments.